nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR1A—stomach cancer	0.603	1	CbGaD
Apomorphine—HTR2A—myenteric nerve plexus—stomach cancer	0.00677	0.136	CbGeAlD
Apomorphine—HTR2A—vagus nerve—stomach cancer	0.00451	0.0904	CbGeAlD
Apomorphine—HTR2A—vein—stomach cancer	0.00436	0.0874	CbGeAlD
Apomorphine—Injection site reaction—Mitomycin—stomach cancer	0.00376	0.0274	CcSEcCtD
Apomorphine—Cardiac failure congestive—Mitomycin—stomach cancer	0.00302	0.022	CcSEcCtD
Apomorphine—Angina pectoris—Floxuridine—stomach cancer	0.00294	0.0214	CcSEcCtD
Apomorphine—HTR1B—blood vessel—stomach cancer	0.00288	0.0577	CbGeAlD
Apomorphine—CALY—endocrine gland—stomach cancer	0.00281	0.0563	CbGeAlD
Apomorphine—HTR1D—blood vessel—stomach cancer	0.00279	0.0558	CbGeAlD
Apomorphine—DRD5—hematopoietic system—stomach cancer	0.00248	0.0496	CbGeAlD
Apomorphine—Drowsiness—Mitomycin—stomach cancer	0.00211	0.0154	CcSEcCtD
Apomorphine—CALY—lymph node—stomach cancer	0.00194	0.0389	CbGeAlD
Apomorphine—ADRA1D—epithelium—stomach cancer	0.00181	0.0363	CbGeAlD
Apomorphine—DRD5—lymphoid tissue—stomach cancer	0.00174	0.0349	CbGeAlD
Apomorphine—Confusional state—Floxuridine—stomach cancer	0.00173	0.0126	CcSEcCtD
Apomorphine—Syncope—Mitomycin—stomach cancer	0.00148	0.0108	CcSEcCtD
Apomorphine—Loss of consciousness—Mitomycin—stomach cancer	0.00145	0.0106	CcSEcCtD
Apomorphine—DRD5—endocrine gland—stomach cancer	0.00142	0.0285	CbGeAlD
Apomorphine—Feeling abnormal—Floxuridine—stomach cancer	0.00142	0.0103	CcSEcCtD
Apomorphine—Rhinorrhoea—Docetaxel—stomach cancer	0.0014	0.0102	CcSEcCtD
Apomorphine—HTR2A—blood vessel—stomach cancer	0.00138	0.0277	CbGeAlD
Apomorphine—Confusional state—Mitomycin—stomach cancer	0.00136	0.0099	CcSEcCtD
Apomorphine—Rhinorrhoea—Capecitabine—stomach cancer	0.00136	0.00987	CcSEcCtD
Apomorphine—Oedema—Mitomycin—stomach cancer	0.00135	0.00982	CcSEcCtD
Apomorphine—Shock—Mitomycin—stomach cancer	0.00133	0.00966	CcSEcCtD
Apomorphine—Swelling—Fluorouracil—stomach cancer	0.00129	0.00942	CcSEcCtD
Apomorphine—Contusion—Capecitabine—stomach cancer	0.00126	0.00917	CcSEcCtD
Apomorphine—HTR1A—hematopoietic system—stomach cancer	0.00124	0.0248	CbGeAlD
Apomorphine—Asthenia—Floxuridine—stomach cancer	0.00123	0.00898	CcSEcCtD
Apomorphine—HTR2B—smooth muscle tissue—stomach cancer	0.00122	0.0244	CbGeAlD
Apomorphine—Dyspnoea—Mitomycin—stomach cancer	0.0012	0.00875	CcSEcCtD
Apomorphine—Somnolence—Mitomycin—stomach cancer	0.0012	0.00873	CcSEcCtD
Apomorphine—Diarrhoea—Floxuridine—stomach cancer	0.00118	0.00856	CcSEcCtD
Apomorphine—Fatigue—Mitomycin—stomach cancer	0.00116	0.00847	CcSEcCtD
Apomorphine—ADRA1D—endocrine gland—stomach cancer	0.00114	0.0228	CbGeAlD
Apomorphine—Injection site reaction—Docetaxel—stomach cancer	0.00113	0.00821	CcSEcCtD
Apomorphine—Feeling abnormal—Mitomycin—stomach cancer	0.00111	0.00809	CcSEcCtD
Apomorphine—Dehydration—Irinotecan—stomach cancer	0.00111	0.00807	CcSEcCtD
Apomorphine—Vomiting—Floxuridine—stomach cancer	0.00109	0.00796	CcSEcCtD
Apomorphine—Injection site reaction—Capecitabine—stomach cancer	0.00109	0.00795	CcSEcCtD
Apomorphine—Orthostatic hypotension—Irinotecan—stomach cancer	0.00109	0.00792	CcSEcCtD
Apomorphine—Headache—Floxuridine—stomach cancer	0.00108	0.00784	CcSEcCtD
Apomorphine—Nausea—Floxuridine—stomach cancer	0.00102	0.00743	CcSEcCtD
Apomorphine—Nasopharyngitis—Fluorouracil—stomach cancer	0.00102	0.00743	CcSEcCtD
Apomorphine—Angina pectoris—Irinotecan—stomach cancer	0.001	0.00731	CcSEcCtD
Apomorphine—Sweating increased—Irinotecan—stomach cancer	0.001	0.00731	CcSEcCtD
Apomorphine—Ecchymosis—Capecitabine—stomach cancer	0.000993	0.00723	CcSEcCtD
Apomorphine—Asthenia—Mitomycin—stomach cancer	0.000967	0.00705	CcSEcCtD
Apomorphine—Angina pectoris—Fluorouracil—stomach cancer	0.00096	0.007	CcSEcCtD
Apomorphine—HTR2B—digestive system—stomach cancer	0.00096	0.0192	CbGeAlD
Apomorphine—Swelling—Docetaxel—stomach cancer	0.000933	0.0068	CcSEcCtD
Apomorphine—Pneumonia—Irinotecan—stomach cancer	0.000923	0.00673	CcSEcCtD
Apomorphine—Diarrhoea—Mitomycin—stomach cancer	0.000922	0.00672	CcSEcCtD
Apomorphine—Cardiac failure congestive—Docetaxel—stomach cancer	0.000908	0.00661	CcSEcCtD
Apomorphine—Swelling—Capecitabine—stomach cancer	0.000904	0.00658	CcSEcCtD
Apomorphine—Dizziness—Mitomycin—stomach cancer	0.000891	0.00649	CcSEcCtD
Apomorphine—ADRA2C—pancreas—stomach cancer	0.000885	0.0177	CbGeAlD
Apomorphine—Pneumonia—Fluorouracil—stomach cancer	0.000884	0.00644	CcSEcCtD
Apomorphine—HTR1B—endocrine gland—stomach cancer	0.000881	0.0176	CbGeAlD
Apomorphine—ADRA2A—hematopoietic system—stomach cancer	0.000867	0.0174	CbGeAlD
Apomorphine—Vomiting—Mitomycin—stomach cancer	0.000857	0.00624	CcSEcCtD
Apomorphine—Urinary tract infection—Fluorouracil—stomach cancer	0.000855	0.00622	CcSEcCtD
Apomorphine—Headache—Mitomycin—stomach cancer	0.000844	0.00615	CcSEcCtD
Apomorphine—Pain in extremity—Docetaxel—stomach cancer	0.000823	0.006	CcSEcCtD
Apomorphine—Dyskinesia—Epirubicin—stomach cancer	0.000814	0.00593	CcSEcCtD
Apomorphine—Nausea—Mitomycin—stomach cancer	0.000801	0.00583	CcSEcCtD
Apomorphine—Pain in extremity—Capecitabine—stomach cancer	0.000797	0.00581	CcSEcCtD
Apomorphine—Disturbance in sexual arousal—Capecitabine—stomach cancer	0.000791	0.00576	CcSEcCtD
Apomorphine—Dehydration—Docetaxel—stomach cancer	0.000766	0.00558	CcSEcCtD
Apomorphine—Flushing—Irinotecan—stomach cancer	0.000765	0.00557	CcSEcCtD
Apomorphine—Injection site reaction—Epirubicin—stomach cancer	0.000761	0.00554	CcSEcCtD
Apomorphine—Dyskinesia—Doxorubicin—stomach cancer	0.000753	0.00549	CcSEcCtD
Apomorphine—Orthostatic hypotension—Docetaxel—stomach cancer	0.000752	0.00548	CcSEcCtD
Apomorphine—Dehydration—Capecitabine—stomach cancer	0.000741	0.0054	CcSEcCtD
Apomorphine—Ecchymosis—Methotrexate—stomach cancer	0.000739	0.00538	CcSEcCtD
Apomorphine—HTR2A—hematopoietic system—stomach cancer	0.000737	0.0148	CbGeAlD
Apomorphine—Nasopharyngitis—Docetaxel—stomach cancer	0.000736	0.00536	CcSEcCtD
Apomorphine—Orthostatic hypotension—Capecitabine—stomach cancer	0.000728	0.0053	CcSEcCtD
Apomorphine—Nasopharyngitis—Capecitabine—stomach cancer	0.000713	0.00519	CcSEcCtD
Apomorphine—HTR1A—endocrine gland—stomach cancer	0.000711	0.0142	CbGeAlD
Apomorphine—ADRA2A—pancreas—stomach cancer	0.000706	0.0141	CbGeAlD
Apomorphine—Injection site reaction—Doxorubicin—stomach cancer	0.000704	0.00513	CcSEcCtD
Apomorphine—Back pain—Irinotecan—stomach cancer	0.000694	0.00505	CcSEcCtD
Apomorphine—Angina pectoris—Docetaxel—stomach cancer	0.000693	0.00505	CcSEcCtD
Apomorphine—Ecchymosis—Epirubicin—stomach cancer	0.000692	0.00504	CcSEcCtD
Apomorphine—HTR2A—epithelium—stomach cancer	0.000674	0.0135	CbGeAlD
Apomorphine—Angina pectoris—Capecitabine—stomach cancer	0.000671	0.00489	CcSEcCtD
Apomorphine—Sweating increased—Capecitabine—stomach cancer	0.000671	0.00489	CcSEcCtD
Apomorphine—HTR2A—smooth muscle tissue—stomach cancer	0.000649	0.013	CbGeAlD
Apomorphine—Syncope—Irinotecan—stomach cancer	0.000643	0.00469	CcSEcCtD
Apomorphine—DRD2—endocrine gland—stomach cancer	0.000642	0.0129	CbGeAlD
Apomorphine—Ecchymosis—Doxorubicin—stomach cancer	0.00064	0.00466	CcSEcCtD
Apomorphine—Pneumonia—Docetaxel—stomach cancer	0.000638	0.00465	CcSEcCtD
Apomorphine—Loss of consciousness—Irinotecan—stomach cancer	0.00063	0.00459	CcSEcCtD
Apomorphine—Pneumonia—Capecitabine—stomach cancer	0.000618	0.0045	CcSEcCtD
Apomorphine—Cardiac failure congestive—Epirubicin—stomach cancer	0.000612	0.00446	CcSEcCtD
Apomorphine—Urinary tract infection—Capecitabine—stomach cancer	0.000597	0.00435	CcSEcCtD
Apomorphine—Confusional state—Irinotecan—stomach cancer	0.00059	0.0043	CcSEcCtD
Apomorphine—Oedema—Irinotecan—stomach cancer	0.000585	0.00426	CcSEcCtD
Apomorphine—Chest pain—Fluorouracil—stomach cancer	0.000585	0.00426	CcSEcCtD
Apomorphine—Shock—Irinotecan—stomach cancer	0.000576	0.0042	CcSEcCtD
Apomorphine—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000567	0.00413	CcSEcCtD
Apomorphine—Hyperhidrosis—Irinotecan—stomach cancer	0.000566	0.00412	CcSEcCtD
Apomorphine—Confusional state—Fluorouracil—stomach cancer	0.000565	0.00412	CcSEcCtD
Apomorphine—ADRA2C—liver—stomach cancer	0.000563	0.0113	CbGeAlD
Apomorphine—Oedema—Fluorouracil—stomach cancer	0.000561	0.00408	CcSEcCtD
Apomorphine—Pain in extremity—Epirubicin—stomach cancer	0.000555	0.00405	CcSEcCtD
Apomorphine—HTR2B—lymph node—stomach cancer	0.000548	0.011	CbGeAlD
Apomorphine—Hypotension—Irinotecan—stomach cancer	0.000547	0.00398	CcSEcCtD
Apomorphine—Insomnia—Irinotecan—stomach cancer	0.000529	0.00386	CcSEcCtD
Apomorphine—Flushing—Docetaxel—stomach cancer	0.000529	0.00385	CcSEcCtD
Apomorphine—Hypotension—Fluorouracil—stomach cancer	0.000524	0.00382	CcSEcCtD
Apomorphine—Dyspnoea—Irinotecan—stomach cancer	0.000522	0.0038	CcSEcCtD
Apomorphine—Somnolence—Irinotecan—stomach cancer	0.00052	0.00379	CcSEcCtD
Apomorphine—Dehydration—Epirubicin—stomach cancer	0.000516	0.00376	CcSEcCtD
Apomorphine—Pain in extremity—Doxorubicin—stomach cancer	0.000514	0.00374	CcSEcCtD
Apomorphine—HTR2A—digestive system—stomach cancer	0.000513	0.0103	CbGeAlD
Apomorphine—Flushing—Capecitabine—stomach cancer	0.000512	0.00373	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000511	0.00372	CcSEcCtD
Apomorphine—Orthostatic hypotension—Epirubicin—stomach cancer	0.000507	0.0037	CcSEcCtD
Apomorphine—Insomnia—Fluorouracil—stomach cancer	0.000507	0.00369	CcSEcCtD
Apomorphine—Fatigue—Irinotecan—stomach cancer	0.000505	0.00368	CcSEcCtD
Apomorphine—Constipation—Irinotecan—stomach cancer	0.000501	0.00365	CcSEcCtD
Apomorphine—Dyspnoea—Fluorouracil—stomach cancer	0.0005	0.00364	CcSEcCtD
Apomorphine—Mental disorder—Docetaxel—stomach cancer	0.000499	0.00364	CcSEcCtD
Apomorphine—Somnolence—Fluorouracil—stomach cancer	0.000498	0.00363	CcSEcCtD
Apomorphine—ADRA2A—endocrine gland—stomach cancer	0.000498	0.00998	CbGeAlD
Apomorphine—Nasopharyngitis—Epirubicin—stomach cancer	0.000497	0.00362	CcSEcCtD
Apomorphine—Mental disorder—Capecitabine—stomach cancer	0.000483	0.00352	CcSEcCtD
Apomorphine—Feeling abnormal—Irinotecan—stomach cancer	0.000482	0.00351	CcSEcCtD
Apomorphine—Back pain—Docetaxel—stomach cancer	0.00048	0.00349	CcSEcCtD
Apomorphine—Dehydration—Doxorubicin—stomach cancer	0.000478	0.00348	CcSEcCtD
Apomorphine—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000469	0.00342	CcSEcCtD
Apomorphine—Angina pectoris—Epirubicin—stomach cancer	0.000468	0.00341	CcSEcCtD
Apomorphine—Back pain—Capecitabine—stomach cancer	0.000464	0.00338	CcSEcCtD
Apomorphine—Feeling abnormal—Fluorouracil—stomach cancer	0.000462	0.00337	CcSEcCtD
Apomorphine—Pneumonia—Methotrexate—stomach cancer	0.00046	0.00335	CcSEcCtD
Apomorphine—Nasopharyngitis—Doxorubicin—stomach cancer	0.00046	0.00335	CcSEcCtD
Apomorphine—Drowsiness—Methotrexate—stomach cancer	0.000457	0.00333	CcSEcCtD
Apomorphine—Syncope—Docetaxel—stomach cancer	0.000445	0.00324	CcSEcCtD
Apomorphine—Loss of consciousness—Docetaxel—stomach cancer	0.000436	0.00317	CcSEcCtD
Apomorphine—Angina pectoris—Doxorubicin—stomach cancer	0.000433	0.00315	CcSEcCtD
Apomorphine—ADRA2C—lymph node—stomach cancer	0.000432	0.00864	CbGeAlD
Apomorphine—Syncope—Capecitabine—stomach cancer	0.000431	0.00314	CcSEcCtD
Apomorphine—Pneumonia—Epirubicin—stomach cancer	0.00043	0.00314	CcSEcCtD
Apomorphine—Drowsiness—Epirubicin—stomach cancer	0.000428	0.00312	CcSEcCtD
Apomorphine—HTR2A—endocrine gland—stomach cancer	0.000424	0.00848	CbGeAlD
Apomorphine—Arthralgia—Docetaxel—stomach cancer	0.000422	0.00308	CcSEcCtD
Apomorphine—Chest pain—Docetaxel—stomach cancer	0.000422	0.00308	CcSEcCtD
Apomorphine—Loss of consciousness—Capecitabine—stomach cancer	0.000422	0.00307	CcSEcCtD
Apomorphine—Asthenia—Irinotecan—stomach cancer	0.00042	0.00306	CcSEcCtD
Apomorphine—Urinary tract infection—Epirubicin—stomach cancer	0.000416	0.00303	CcSEcCtD
Apomorphine—Chest pain—Capecitabine—stomach cancer	0.000409	0.00298	CcSEcCtD
Apomorphine—Arthralgia—Capecitabine—stomach cancer	0.000409	0.00298	CcSEcCtD
Apomorphine—Confusional state—Docetaxel—stomach cancer	0.000408	0.00297	CcSEcCtD
Apomorphine—Anxiety—Capecitabine—stomach cancer	0.000407	0.00297	CcSEcCtD
Apomorphine—Oedema—Docetaxel—stomach cancer	0.000405	0.00295	CcSEcCtD
Apomorphine—Diarrhoea—Irinotecan—stomach cancer	0.000401	0.00292	CcSEcCtD
Apomorphine—Pneumonia—Doxorubicin—stomach cancer	0.000398	0.0029	CcSEcCtD
Apomorphine—Shock—Docetaxel—stomach cancer	0.000398	0.0029	CcSEcCtD
Apomorphine—Pruritus—Fluorouracil—stomach cancer	0.000397	0.00289	CcSEcCtD
Apomorphine—Drowsiness—Doxorubicin—stomach cancer	0.000396	0.00288	CcSEcCtD
Apomorphine—Confusional state—Capecitabine—stomach cancer	0.000395	0.00288	CcSEcCtD
Apomorphine—Oedema—Capecitabine—stomach cancer	0.000392	0.00285	CcSEcCtD
Apomorphine—Dizziness—Irinotecan—stomach cancer	0.000387	0.00282	CcSEcCtD
Apomorphine—Shock—Capecitabine—stomach cancer	0.000385	0.00281	CcSEcCtD
Apomorphine—Urinary tract infection—Doxorubicin—stomach cancer	0.000385	0.0028	CcSEcCtD
Apomorphine—Diarrhoea—Fluorouracil—stomach cancer	0.000384	0.00279	CcSEcCtD
Apomorphine—HTR2A—liver—stomach cancer	0.000382	0.00765	CbGeAlD
Apomorphine—Hyperhidrosis—Capecitabine—stomach cancer	0.000379	0.00276	CcSEcCtD
Apomorphine—Hypotension—Docetaxel—stomach cancer	0.000378	0.00275	CcSEcCtD
Apomorphine—Vomiting—Irinotecan—stomach cancer	0.000372	0.00271	CcSEcCtD
Apomorphine—Dizziness—Fluorouracil—stomach cancer	0.000371	0.0027	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000369	0.00269	CcSEcCtD
Apomorphine—Headache—Irinotecan—stomach cancer	0.000367	0.00267	CcSEcCtD
Apomorphine—Hypotension—Capecitabine—stomach cancer	0.000366	0.00267	CcSEcCtD
Apomorphine—Insomnia—Docetaxel—stomach cancer	0.000366	0.00267	CcSEcCtD
Apomorphine—Dyspnoea—Docetaxel—stomach cancer	0.000361	0.00263	CcSEcCtD
Apomorphine—Somnolence—Docetaxel—stomach cancer	0.00036	0.00262	CcSEcCtD
Apomorphine—Mental disorder—Methotrexate—stomach cancer	0.00036	0.00262	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000357	0.0026	CcSEcCtD
Apomorphine—Flushing—Epirubicin—stomach cancer	0.000357	0.0026	CcSEcCtD
Apomorphine—Vomiting—Fluorouracil—stomach cancer	0.000356	0.0026	CcSEcCtD
Apomorphine—Insomnia—Capecitabine—stomach cancer	0.000354	0.00258	CcSEcCtD
Apomorphine—Headache—Fluorouracil—stomach cancer	0.000351	0.00256	CcSEcCtD
Apomorphine—Dyspnoea—Capecitabine—stomach cancer	0.000349	0.00254	CcSEcCtD
Apomorphine—Fatigue—Docetaxel—stomach cancer	0.000349	0.00254	CcSEcCtD
Apomorphine—Nausea—Irinotecan—stomach cancer	0.000348	0.00253	CcSEcCtD
Apomorphine—Constipation—Docetaxel—stomach cancer	0.000346	0.00252	CcSEcCtD
Apomorphine—Back pain—Methotrexate—stomach cancer	0.000346	0.00252	CcSEcCtD
Apomorphine—ADRA2A—lymph node—stomach cancer	0.000344	0.0069	CbGeAlD
Apomorphine—Fatigue—Capecitabine—stomach cancer	0.000338	0.00246	CcSEcCtD
Apomorphine—Mental disorder—Epirubicin—stomach cancer	0.000337	0.00245	CcSEcCtD
Apomorphine—Constipation—Capecitabine—stomach cancer	0.000335	0.00244	CcSEcCtD
Apomorphine—Feeling abnormal—Docetaxel—stomach cancer	0.000333	0.00243	CcSEcCtD
Apomorphine—Nausea—Fluorouracil—stomach cancer	0.000333	0.00243	CcSEcCtD
Apomorphine—Flushing—Doxorubicin—stomach cancer	0.00033	0.0024	CcSEcCtD
Apomorphine—Back pain—Epirubicin—stomach cancer	0.000324	0.00236	CcSEcCtD
Apomorphine—Feeling abnormal—Capecitabine—stomach cancer	0.000323	0.00235	CcSEcCtD
Apomorphine—Mental disorder—Doxorubicin—stomach cancer	0.000311	0.00227	CcSEcCtD
Apomorphine—Chest pain—Methotrexate—stomach cancer	0.000304	0.00222	CcSEcCtD
Apomorphine—Arthralgia—Methotrexate—stomach cancer	0.000304	0.00222	CcSEcCtD
Apomorphine—Syncope—Epirubicin—stomach cancer	0.0003	0.00218	CcSEcCtD
Apomorphine—Back pain—Doxorubicin—stomach cancer	0.000299	0.00218	CcSEcCtD
Apomorphine—Confusional state—Methotrexate—stomach cancer	0.000294	0.00214	CcSEcCtD
Apomorphine—Loss of consciousness—Epirubicin—stomach cancer	0.000294	0.00214	CcSEcCtD
Apomorphine—Asthenia—Docetaxel—stomach cancer	0.00029	0.00212	CcSEcCtD
Apomorphine—Pruritus—Docetaxel—stomach cancer	0.000286	0.00209	CcSEcCtD
Apomorphine—Arthralgia—Epirubicin—stomach cancer	0.000285	0.00207	CcSEcCtD
Apomorphine—Chest pain—Epirubicin—stomach cancer	0.000285	0.00207	CcSEcCtD
Apomorphine—Anxiety—Epirubicin—stomach cancer	0.000284	0.00207	CcSEcCtD
Apomorphine—Hyperhidrosis—Methotrexate—stomach cancer	0.000282	0.00205	CcSEcCtD
Apomorphine—Asthenia—Capecitabine—stomach cancer	0.000281	0.00205	CcSEcCtD
Apomorphine—Syncope—Doxorubicin—stomach cancer	0.000278	0.00202	CcSEcCtD
Apomorphine—Pruritus—Capecitabine—stomach cancer	0.000277	0.00202	CcSEcCtD
Apomorphine—Diarrhoea—Docetaxel—stomach cancer	0.000277	0.00202	CcSEcCtD
Apomorphine—Confusional state—Epirubicin—stomach cancer	0.000275	0.002	CcSEcCtD
Apomorphine—Oedema—Epirubicin—stomach cancer	0.000273	0.00199	CcSEcCtD
Apomorphine—Hypotension—Methotrexate—stomach cancer	0.000273	0.00199	CcSEcCtD
Apomorphine—Loss of consciousness—Doxorubicin—stomach cancer	0.000272	0.00198	CcSEcCtD
Apomorphine—Shock—Epirubicin—stomach cancer	0.000269	0.00196	CcSEcCtD
Apomorphine—Diarrhoea—Capecitabine—stomach cancer	0.000268	0.00195	CcSEcCtD
Apomorphine—Dizziness—Docetaxel—stomach cancer	0.000268	0.00195	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000266	0.00194	CcSEcCtD
Apomorphine—Hyperhidrosis—Epirubicin—stomach cancer	0.000264	0.00192	CcSEcCtD
Apomorphine—Insomnia—Methotrexate—stomach cancer	0.000264	0.00192	CcSEcCtD
Apomorphine—Arthralgia—Doxorubicin—stomach cancer	0.000263	0.00192	CcSEcCtD
Apomorphine—Chest pain—Doxorubicin—stomach cancer	0.000263	0.00192	CcSEcCtD
Apomorphine—Anxiety—Doxorubicin—stomach cancer	0.000263	0.00191	CcSEcCtD
Apomorphine—Dyspnoea—Methotrexate—stomach cancer	0.00026	0.00189	CcSEcCtD
Apomorphine—Somnolence—Methotrexate—stomach cancer	0.000259	0.00189	CcSEcCtD
Apomorphine—Dizziness—Capecitabine—stomach cancer	0.000259	0.00189	CcSEcCtD
Apomorphine—Vomiting—Docetaxel—stomach cancer	0.000257	0.00187	CcSEcCtD
Apomorphine—Hypotension—Epirubicin—stomach cancer	0.000255	0.00186	CcSEcCtD
Apomorphine—Confusional state—Doxorubicin—stomach cancer	0.000255	0.00186	CcSEcCtD
Apomorphine—Headache—Docetaxel—stomach cancer	0.000254	0.00185	CcSEcCtD
Apomorphine—Oedema—Doxorubicin—stomach cancer	0.000253	0.00184	CcSEcCtD
Apomorphine—Fatigue—Methotrexate—stomach cancer	0.000251	0.00183	CcSEcCtD
Apomorphine—Vomiting—Capecitabine—stomach cancer	0.000249	0.00181	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000249	0.00181	CcSEcCtD
Apomorphine—Shock—Doxorubicin—stomach cancer	0.000248	0.00181	CcSEcCtD
Apomorphine—Insomnia—Epirubicin—stomach cancer	0.000247	0.0018	CcSEcCtD
Apomorphine—Headache—Capecitabine—stomach cancer	0.000245	0.00179	CcSEcCtD
Apomorphine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000244	0.00178	CcSEcCtD
Apomorphine—Dyspnoea—Epirubicin—stomach cancer	0.000243	0.00177	CcSEcCtD
Apomorphine—Somnolence—Epirubicin—stomach cancer	0.000243	0.00177	CcSEcCtD
Apomorphine—Nausea—Docetaxel—stomach cancer	0.00024	0.00175	CcSEcCtD
Apomorphine—Feeling abnormal—Methotrexate—stomach cancer	0.00024	0.00175	CcSEcCtD
Apomorphine—Hypotension—Doxorubicin—stomach cancer	0.000236	0.00172	CcSEcCtD
Apomorphine—Fatigue—Epirubicin—stomach cancer	0.000235	0.00171	CcSEcCtD
Apomorphine—Constipation—Epirubicin—stomach cancer	0.000233	0.0017	CcSEcCtD
Apomorphine—Nausea—Capecitabine—stomach cancer	0.000233	0.0017	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00023	0.00168	CcSEcCtD
Apomorphine—Insomnia—Doxorubicin—stomach cancer	0.000228	0.00166	CcSEcCtD
Apomorphine—Dyspnoea—Doxorubicin—stomach cancer	0.000225	0.00164	CcSEcCtD
Apomorphine—Feeling abnormal—Epirubicin—stomach cancer	0.000225	0.00164	CcSEcCtD
Apomorphine—Somnolence—Doxorubicin—stomach cancer	0.000225	0.00164	CcSEcCtD
Apomorphine—Fatigue—Doxorubicin—stomach cancer	0.000218	0.00159	CcSEcCtD
Apomorphine—Constipation—Doxorubicin—stomach cancer	0.000216	0.00157	CcSEcCtD
Apomorphine—Asthenia—Methotrexate—stomach cancer	0.000209	0.00152	CcSEcCtD
Apomorphine—Feeling abnormal—Doxorubicin—stomach cancer	0.000208	0.00152	CcSEcCtD
Apomorphine—Pruritus—Methotrexate—stomach cancer	0.000206	0.0015	CcSEcCtD
Apomorphine—Diarrhoea—Methotrexate—stomach cancer	0.0002	0.00145	CcSEcCtD
Apomorphine—Asthenia—Epirubicin—stomach cancer	0.000196	0.00143	CcSEcCtD
Apomorphine—Pruritus—Epirubicin—stomach cancer	0.000193	0.00141	CcSEcCtD
Apomorphine—Dizziness—Methotrexate—stomach cancer	0.000193	0.00141	CcSEcCtD
Apomorphine—Diarrhoea—Epirubicin—stomach cancer	0.000187	0.00136	CcSEcCtD
Apomorphine—Vomiting—Methotrexate—stomach cancer	0.000185	0.00135	CcSEcCtD
Apomorphine—Headache—Methotrexate—stomach cancer	0.000183	0.00133	CcSEcCtD
Apomorphine—Asthenia—Doxorubicin—stomach cancer	0.000181	0.00132	CcSEcCtD
Apomorphine—Dizziness—Epirubicin—stomach cancer	0.000181	0.00131	CcSEcCtD
Apomorphine—Pruritus—Doxorubicin—stomach cancer	0.000179	0.0013	CcSEcCtD
Apomorphine—Vomiting—Epirubicin—stomach cancer	0.000174	0.00126	CcSEcCtD
Apomorphine—Nausea—Methotrexate—stomach cancer	0.000173	0.00126	CcSEcCtD
Apomorphine—Diarrhoea—Doxorubicin—stomach cancer	0.000173	0.00126	CcSEcCtD
Apomorphine—Headache—Epirubicin—stomach cancer	0.000171	0.00125	CcSEcCtD
Apomorphine—Dizziness—Doxorubicin—stomach cancer	0.000167	0.00122	CcSEcCtD
Apomorphine—Nausea—Epirubicin—stomach cancer	0.000162	0.00118	CcSEcCtD
Apomorphine—Vomiting—Doxorubicin—stomach cancer	0.000161	0.00117	CcSEcCtD
Apomorphine—Headache—Doxorubicin—stomach cancer	0.000158	0.00115	CcSEcCtD
Apomorphine—Nausea—Doxorubicin—stomach cancer	0.00015	0.00109	CcSEcCtD
Apomorphine—HTR1B—Signaling Pathways—MAPK3—stomach cancer	7.29e-06	3.47e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	7.26e-06	3.46e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—stomach cancer	7.24e-06	3.45e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—stomach cancer	7.24e-06	3.45e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RHOA—stomach cancer	7.23e-06	3.44e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL8—stomach cancer	7.23e-06	3.44e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL8—stomach cancer	7.19e-06	3.42e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—HRAS—stomach cancer	7.18e-06	3.42e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MAPK3—stomach cancer	7.17e-06	3.42e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—STAT3—stomach cancer	7.17e-06	3.41e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	7.16e-06	3.41e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NOS3—stomach cancer	7.15e-06	3.41e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—HRAS—stomach cancer	7.14e-06	3.4e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	7.12e-06	3.39e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RHOA—stomach cancer	7.11e-06	3.39e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—stomach cancer	7.1e-06	3.38e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—stomach cancer	7.09e-06	3.38e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MAPK1—stomach cancer	7.08e-06	3.37e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—EGFR—stomach cancer	7.08e-06	3.37e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	7.06e-06	3.36e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NOS3—stomach cancer	7.04e-06	3.35e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	7.03e-06	3.35e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	7.03e-06	3.35e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	7.02e-06	3.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—stomach cancer	7e-06	3.34e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	6.99e-06	3.33e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—stomach cancer	6.98e-06	3.32e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	6.97e-06	3.32e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—JUN—stomach cancer	6.96e-06	3.31e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	6.95e-06	3.31e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MAPK1—stomach cancer	6.93e-06	3.3e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—EGFR—stomach cancer	6.93e-06	3.3e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	6.88e-06	3.28e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—stomach cancer	6.87e-06	3.27e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MAPK3—stomach cancer	6.85e-06	3.26e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	6.84e-06	3.26e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—stomach cancer	6.84e-06	3.26e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	6.83e-06	3.25e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—stomach cancer	6.83e-06	3.25e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MAPK1—stomach cancer	6.82e-06	3.25e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—EGFR—stomach cancer	6.82e-06	3.25e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	6.81e-06	3.24e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	6.77e-06	3.22e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—STAT3—stomach cancer	6.76e-06	3.22e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	6.75e-06	3.21e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—stomach cancer	6.73e-06	3.21e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	6.73e-06	3.21e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCND1—stomach cancer	6.73e-06	3.21e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	6.72e-06	3.2e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—JUN—stomach cancer	6.72e-06	3.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	6.72e-06	3.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	6.71e-06	3.19e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	6.7e-06	3.19e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCND1—stomach cancer	6.7e-06	3.19e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ERBB2—stomach cancer	6.69e-06	3.19e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—KRAS—stomach cancer	6.69e-06	3.19e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—JUN—stomach cancer	6.68e-06	3.18e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—STAT3—stomach cancer	6.67e-06	3.18e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—STAT3—stomach cancer	6.67e-06	3.18e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—stomach cancer	6.66e-06	3.17e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—stomach cancer	6.65e-06	3.17e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	6.64e-06	3.16e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	6.59e-06	3.14e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	6.58e-06	3.14e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—KRAS—stomach cancer	6.55e-06	3.12e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—stomach cancer	6.54e-06	3.12e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—stomach cancer	6.54e-06	3.11e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCND1—stomach cancer	6.51e-06	3.1e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MAPK1—stomach cancer	6.51e-06	3.1e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—EGFR—stomach cancer	6.51e-06	3.1e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	6.51e-06	3.1e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—stomach cancer	6.5e-06	3.1e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—JUN—stomach cancer	6.5e-06	3.1e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	6.48e-06	3.09e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	6.47e-06	3.08e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MAPK3—stomach cancer	6.46e-06	3.07e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—KRAS—stomach cancer	6.45e-06	3.07e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCND1—stomach cancer	6.41e-06	3.05e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	6.4e-06	3.05e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—JUN—stomach cancer	6.4e-06	3.05e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MAPK3—stomach cancer	6.37e-06	3.03e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	6.37e-06	3.03e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK8—stomach cancer	6.36e-06	3.03e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL8—stomach cancer	6.34e-06	3.02e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—stomach cancer	6.32e-06	3.01e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	6.32e-06	3.01e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—HRAS—stomach cancer	6.3e-06	3e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	6.3e-06	3e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—stomach cancer	6.28e-06	2.99e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	6.24e-06	2.97e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	6.22e-06	2.96e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	6.2e-06	2.95e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	6.2e-06	2.95e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—stomach cancer	6.2e-06	2.95e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	6.2e-06	2.95e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—stomach cancer	6.2e-06	2.95e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—KRAS—stomach cancer	6.15e-06	2.93e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	6.15e-06	2.93e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	6.15e-06	2.93e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MAPK1—stomach cancer	6.14e-06	2.93e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—EGFR—stomach cancer	6.14e-06	2.93e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	6.1e-06	2.9e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	6.1e-06	2.9e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	6.08e-06	2.9e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MAPK1—stomach cancer	6.06e-06	2.89e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	6.06e-06	2.89e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—EGFR—stomach cancer	6.06e-06	2.89e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—EGFR—stomach cancer	6.06e-06	2.89e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	6.05e-06	2.88e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—stomach cancer	6.03e-06	2.87e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	6.02e-06	2.87e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	6.02e-06	2.87e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	5.99e-06	2.85e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—stomach cancer	5.95e-06	2.83e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—stomach cancer	5.94e-06	2.83e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PIK3CA—stomach cancer	5.92e-06	2.82e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCND1—stomach cancer	5.91e-06	2.82e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—JUN—stomach cancer	5.9e-06	2.81e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—stomach cancer	5.87e-06	2.8e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	5.84e-06	2.78e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—stomach cancer	5.82e-06	2.77e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCND1—stomach cancer	5.82e-06	2.77e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—STAT3—stomach cancer	5.81e-06	2.77e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—JUN—stomach cancer	5.8e-06	2.76e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—KRAS—stomach cancer	5.8e-06	2.76e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—STAT3—stomach cancer	5.78e-06	2.75e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	5.75e-06	2.74e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—stomach cancer	5.74e-06	2.73e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—stomach cancer	5.73e-06	2.73e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—KRAS—stomach cancer	5.73e-06	2.73e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—KRAS—stomach cancer	5.73e-06	2.73e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	5.72e-06	2.72e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—HRAS—stomach cancer	5.69e-06	2.71e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	5.68e-06	2.7e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	5.68e-06	2.7e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	5.65e-06	2.69e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—stomach cancer	5.65e-06	2.69e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	5.64e-06	2.69e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	5.63e-06	2.68e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	5.62e-06	2.68e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—stomach cancer	5.59e-06	2.66e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	5.59e-06	2.66e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK8—stomach cancer	5.58e-06	2.66e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—HRAS—stomach cancer	5.57e-06	2.65e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK3—stomach cancer	5.55e-06	2.64e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	5.55e-06	2.64e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	5.53e-06	2.64e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	5.52e-06	2.63e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	5.49e-06	2.62e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—HRAS—stomach cancer	5.48e-06	2.61e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	5.47e-06	2.61e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	5.47e-06	2.61e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—stomach cancer	5.47e-06	2.6e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—stomach cancer	5.44e-06	2.59e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	5.4e-06	2.57e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—stomach cancer	5.4e-06	2.57e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	5.37e-06	2.56e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—stomach cancer	5.37e-06	2.56e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PIK3CA—stomach cancer	5.33e-06	2.54e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—stomach cancer	5.33e-06	2.54e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PIK3CA—stomach cancer	5.3e-06	2.53e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	5.29e-06	2.52e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	5.29e-06	2.52e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK1—stomach cancer	5.28e-06	2.52e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EGFR—stomach cancer	5.28e-06	2.52e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—JUN—stomach cancer	5.28e-06	2.51e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PIK3CA—stomach cancer	5.26e-06	2.51e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	5.26e-06	2.51e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	5.26e-06	2.5e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EGFR—stomach cancer	5.25e-06	2.5e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—stomach cancer	5.24e-06	2.5e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—HRAS—stomach cancer	5.23e-06	2.49e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—stomach cancer	5.23e-06	2.49e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	5.17e-06	2.46e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—stomach cancer	5.16e-06	2.46e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—stomach cancer	5.15e-06	2.45e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—stomach cancer	5.14e-06	2.45e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	5.14e-06	2.45e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	5.12e-06	2.44e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	5.11e-06	2.43e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	5.11e-06	2.43e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—STAT3—stomach cancer	5.1e-06	2.43e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—stomach cancer	5.09e-06	2.42e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—stomach cancer	5.09e-06	2.42e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	5.07e-06	2.41e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	5.03e-06	2.4e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	5.03e-06	2.4e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—STAT3—stomach cancer	5.02e-06	2.39e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—stomach cancer	5.01e-06	2.38e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	5e-06	2.38e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—KRAS—stomach cancer	4.99e-06	2.38e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—KRAS—stomach cancer	4.96e-06	2.36e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—HRAS—stomach cancer	4.93e-06	2.35e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK3—stomach cancer	4.87e-06	2.32e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—HRAS—stomach cancer	4.87e-06	2.32e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—HRAS—stomach cancer	4.87e-06	2.32e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	4.83e-06	2.3e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	4.8e-06	2.28e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	4.75e-06	2.26e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	4.75e-06	2.26e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—stomach cancer	4.74e-06	2.26e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—stomach cancer	4.72e-06	2.25e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—stomach cancer	4.67e-06	2.22e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—stomach cancer	4.66e-06	2.22e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—stomach cancer	4.66e-06	2.22e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK1—stomach cancer	4.64e-06	2.21e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EGFR—stomach cancer	4.64e-06	2.21e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	4.61e-06	2.2e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—stomach cancer	4.59e-06	2.19e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	4.58e-06	2.18e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	4.57e-06	2.18e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	4.56e-06	2.17e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EGFR—stomach cancer	4.56e-06	2.17e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	4.56e-06	2.17e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	4.44e-06	2.11e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—stomach cancer	4.43e-06	2.11e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—stomach cancer	4.41e-06	2.1e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	4.39e-06	2.09e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—KRAS—stomach cancer	4.38e-06	2.09e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	4.37e-06	2.08e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	4.36e-06	2.08e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KRAS—stomach cancer	4.31e-06	2.05e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CA—stomach cancer	4.31e-06	2.05e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—stomach cancer	4.29e-06	2.04e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—stomach cancer	4.24e-06	2.02e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—HRAS—stomach cancer	4.24e-06	2.02e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—stomach cancer	4.22e-06	2.01e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—HRAS—stomach cancer	4.22e-06	2.01e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—stomach cancer	4.21e-06	2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	4.15e-06	1.98e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	4.15e-06	1.98e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	4.1e-06	1.95e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—stomach cancer	4.06e-06	1.93e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	4.04e-06	1.92e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—stomach cancer	4.04e-06	1.92e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	4.02e-06	1.92e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	3.96e-06	1.89e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—stomach cancer	3.93e-06	1.87e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	3.92e-06	1.87e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—stomach cancer	3.89e-06	1.85e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—stomach cancer	3.87e-06	1.84e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—stomach cancer	3.83e-06	1.82e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—HRAS—stomach cancer	3.72e-06	1.77e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—HRAS—stomach cancer	3.66e-06	1.74e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	3.6e-06	1.72e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—stomach cancer	3.56e-06	1.7e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—stomach cancer	3.51e-06	1.67e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—stomach cancer	3.49e-06	1.66e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	3.33e-06	1.59e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—stomach cancer	3.19e-06	1.52e-05	CbGpPWpGaD
